Algocell

📍 Rehovot, Israel🗓 Founded 2023👥 13 employees💰 Last funded Jun 2025
Software Development🌐 algocell.ai
Website LinkedIn
Algocells platform for bioprocess optimization is designed for cell-based companies, including those in precision fermentation and cell culture, serving industries such as food, pharma, and biomaterials. At its core, the platform creates a Bioprocess Simulator powered by hybrid models and AI technology. Algocells platform accelerates time to market by replacing costly, time-consuming trial-and-error methods with simulated experiments. Additionally, it enhances manufacturing processes by delivering real-time predictions and insights, ensuring efficiency and precision in production.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Algocell?
Algocell has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Algocell last raise funding?
The most recent investment in Algocell recorded on gritt.io was in June 2025.
When was Algocell founded?
Algocell was founded in 2023.
What industry is Algocell in?
Algocell operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Algocell based?
Algocell is headquartered in Rehovot, Israel.